Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer

Clinical trial NCT07276880 · RECRUITING

Trial details

NCT number: NCT07276880
Sponsor: UNC Lineberger Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Triple Negative Breast Cancer (TNBC)HER2-Negative Breast Carcinoma Node-positive Breast Cancer

Start date: 2026-03-17
Primary completion: 2027-11-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.